tykhr
sign in
free sign up
Cyclacel Pharmaceuticals Inc
Biotechnology
Healthcare
CYCC
1.58 M shares
NASDAQ US
traded
11 Sep 2025
listed
no
open
6.76
52 week high
17.15
high
6.98
52 week low
0.00
low
6.10
growth
218.50 %
previous Close
6.77
P/E ratio
market cap
11.90 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-1.32 K
98.37 %
eps
0.00 %
-184.64 %
eps surprise
0.00 %
net profit margin
-131800.00 %
-231.00 %
operating incoming
-1.32 M
73.85 %
net change in cash
825
163.58 %
cash on hand
4.28 K
-99.88 %
cost of revenue
0.00 %
top